Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04495725 · ClinicalTrials.gov registry record · NA

Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain

A NA study of Chronic Pain and Opioid Use, sponsored by Vireo Health.

Completed
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT04495725 is a NA study of Chronic Pain and Opioid Use that has completed, run by Vireo Health. The registered enrollment target is 270 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04495725, a NA study of Chronic Pain and Opioid Use, has completed, sponsored by Vireo Health.

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

This study will examine how discounted vouchers for medical cannabis use affects opioid analgesic use in adults with chronic pain. Our study findings will have critically important implications to shape clinical care and medical cannabis policies.

Interventions

  • OTHER Discounted Vouchers for Medical Cannabis Soft-Gel Capsule Products

Study Locations (1)

New York

  • Vireo Health of New York - Queens

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2020-10-06
Est. Completion 2024-03-13
Phase NA

Sponsor

Vireo Health

2 total trials

What the Registry Record Tells You About NCT04495725

The ClinicalTrials.gov registry entry for NCT04495725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower). The listed sponsor is Vireo Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Discounted Vouchers for Medical Cannabis Soft-Gel Capsule Products is the first listed.

NCT04495725 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04495725 about?

NCT04495725 is a clinical study titled "Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain". This study will examine how discounted vouchers for medical cannabis use affects opioid analgesic use in adults with chronic pain. Our study findings will have critically important implications to shape clinical care and medical cannabis policies.

What is the current status of trial NCT04495725?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2020-10-06. Estimated completion is 2024-03-13.

What conditions does trial NCT04495725 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use, Marijuana.

What interventions are being tested in trial NCT04495725?

The interventions under investigation include: Discounted Vouchers for Medical Cannabis Soft-Gel Capsule Products (OTHER).

Who is sponsoring clinical trial NCT04495725?

This trial is sponsored by Vireo Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04495725 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.